Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-20,680
Closed -$914K 418
2024
Q1
$914K Sell
20,680
-32,164
-61% -$1.47M 0.09% 348
2023
Q4
$2.43M Buy
52,844
+34,196
+183% +$1.45M 0.26% 135
2023
Q3
$801K Buy
+18,648
New +$869K 0.1% 336
2023
Q2
Sell
-22,187
Closed -$1.08M 702
2023
Q1
$1.08M Buy
+22,187
New +$1.13M 0.12% 289
2022
Q4
Sell
-6,961
Closed -$305K 741
2022
Q3
$305K Buy
+6,961
New +$344K 0.03% 457

Other funds holding QGEN

Duality Advisers's QGEN Position: Q2 2024 in Review

Duality Advisers sold out of Qiagen (QGEN) in Q2 2024, closing a stake of 20,680 shares — an estimated $914K sold.

Duality Advisers first reported a position in QGEN in Q3 2022 and held it in 5 quarters. The position peaked at $2.43M in Q4 2023. 304 funds tracked by Wall St. Rank hold QGEN as of Q2 2024.

  • Duality Advisers reported no remaining Qiagen position as of Q2 2024 after selling out during the quarter.
  • Duality Advisers sold 20,680 Qiagen shares in Q2 2024, an estimated $914K.
  • Duality Advisers first reported a position in Qiagen in Q3 2022 and held it in 5 quarters.
  • Duality Advisers's Qiagen position peaked at $2.43M in Q4 2023.
  • 304 funds tracked by Wall St. Rank held Qiagen as of Q2 2024.

Based on Duality Advisers's 13F filing for Q2 2024.